Daily Oncology News

Biosimilar Promising for Treatment of ERBB2+ Breast Cancer

Biosimilar Promising for Treatment of ERBB2+ Breast Cancer

Equivalent response rate for women with ERBB2-positive metastatic breast cancer receiving taxanes

CDC: Fewer U.S. Families Struggling With Medical Costs

CDC: Fewer U.S. Families Struggling With Medical Costs

More Americans are experiencing relief with medical bills, but there is still room for improvement.

Smoking Cessation at Any Age Beneficial

Smoking Cessation at Any Age Beneficial

Even patients that quit smoking in their 60s can add years to their lives, researchers find.

USPSTF Continues Recommendations Against Thyroid Cancer Screening

USPSTF Continues Recommendations Against Thyroid Cancer Screening

Widespread routine thyroid cancer screening can lead to overdiagnosis and overtreatment, the USPSTF contends.

Guidelines Issued for Prostate MRI After Negative Biopsy

Guidelines Issued for Prostate MRI After Negative Biopsy

Consensus statement presents guidelines for prostate magnetic resonance imaging (MRI) in patients with negative biopsy.

Intermittent Hypoxia Promotes Lung Tumor Cell Aggressiveness

Intermittent Hypoxia Promotes Lung Tumor Cell Aggressiveness

IH-induced exosomes from mice significantly promote TC1 malignant properties, according to a recent study.

Cancer Patients Benefit From Exercise Both During and After Treatment

Cancer Patients Benefit From Exercise Both During and After Treatment

Studies show better physical function and quality of life for cancer patients who do strength training or aerobic activity.

CDC: Tobacco-Linked Cancers Still Make Up 40 Percent of All Cancers

CDC: Tobacco-Linked Cancers Still Make Up 40 Percent of All Cancers

Fewer people smoking, but cancer burden still high in the U.S.

Long-Term Health Not Improved for Childhood Cancer Survivors

Long-Term Health Not Improved for Childhood Cancer Survivors

Research shows only modest improvements in the physical or mental health of childhood cancer survivors in recent decades.

Second Opinions Rarely Change Prostate Cancer Decisions

Second Opinions Rarely Change Prostate Cancer Decisions

The impact of additional opinions on patient decision-making is limited.

Sign Up for Free e-newsletters

Regimen and Drug Listings

GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION

Bone Cancer Regimens Drugs
Brain Cancer Regimens Drugs
Breast Cancer Regimens Drugs
Endocrine Cancer Regimens Drugs
Gastrointestinal Cancer Regimens Drugs
Genitourinary Cancer Regimens Drugs
Gynecologic Cancer Regimens Drugs
Head and Neck Cancer Regimens Drugs
Hematologic Cancer Regimens Drugs
Lung Cancer Regimens Drugs
Other Cancers Regimens
Rare Cancers Regimens
Skin Cancer Regimens Drugs